BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 24839354)

  • 1. The regulation of inflammatory mediators in acute kidney injury via exogenous mesenchymal stem cells.
    Du T; Zhu YJ
    Mediators Inflamm; 2014; 2014():261697. PubMed ID: 24839354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Beneficial Effects of Mesenchymal Stem Cells in Acute Kidney Injury: A Narrative Review.
    Liu Y; Han J; Fang J; Li R
    Curr Stem Cell Res Ther; 2024; 19(2):200-209. PubMed ID: 36748221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human mesenchymal stromal cells ameliorate complement induced inflammatory cascade and improve renal functions in a rat model of ischemia-reperfusion induced acute kidney injury.
    Zilberman-Itskovich S; Abu-Hamad R; Zarura R; Sova M; Hachmo Y; Stark M; Neuman S; Slavin S; Efrati S
    PLoS One; 2019; 14(9):e0222354. PubMed ID: 31513644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene-modified Mesenchymal Stem Cell-based Therapy in Renal Ischemia- Reperfusion Injury.
    Xu H; Chen C; Hu L; Hou J
    Curr Gene Ther; 2017; 17(6):453-460. PubMed ID: 29446737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular Mechanisms of Mesenchymal Stem Cell-Based Therapy in Acute Kidney Injury.
    Lee PW; Wu BS; Yang CY; Lee OK
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renoprotective effect of human umbilical cord-derived mesenchymal stem cells in immunodeficient mice suffering from acute kidney injury.
    Fang TC; Pang CY; Chiu SC; Ding DC; Tsai RK
    PLoS One; 2012; 7(9):e46504. PubMed ID: 23029541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mesenchymal stem cells in kidney inflammation and repair.
    Wise AF; Ricardo SD
    Nephrology (Carlton); 2012 Jan; 17(1):1-10. PubMed ID: 21777348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced renoprotective effect of IGF-1 modified human umbilical cord-derived mesenchymal stem cells on gentamicin-induced acute kidney injury.
    Liu P; Feng Y; Dong D; Liu X; Chen Y; Wang Y; Zhou Y
    Sci Rep; 2016 Feb; 6():20287. PubMed ID: 26830766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Mesenchymal stem cells attenuate acute kidney injury via regulation of natural immune system].
    Hu J; Zhang L; Cui S; Zhu F; Li D; Feng Z; Chen X
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2016 Mar; 28(3):235-40. PubMed ID: 29917337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mesenchymal stromal cell-based therapies for acute kidney injury: progress in the last decade.
    Fazekas B; Griffin MD
    Kidney Int; 2020 Jun; 97(6):1130-1140. PubMed ID: 32305128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adipose-derived mesenchymal stem cells therapy for acute kidney injury induced by ischemia-reperfusion in a rat model.
    Zhang JB; Wang XQ; Lu GL; Huang HS; Xu SY
    Clin Exp Pharmacol Physiol; 2017 Dec; 44(12):1232-1240. PubMed ID: 28688148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunomodulatory Effects of Mesenchymal Stem Cells on Drug-Induced Acute Kidney Injury.
    Han Q; Wang X; Ding X; He J; Cai G; Zhu H
    Front Immunol; 2021; 12():683003. PubMed ID: 34149721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of combination of vitamin E and umbilical cord-derived mesenchymal stem cells on inflammation in mice with acute kidney injury.
    Guo Q; Wang J
    Immunopharmacol Immunotoxicol; 2018 Apr; 40(2):168-172. PubMed ID: 29355065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mesenchymal stem cell therapy in acute kidney injury (AKI): review and perspectives.
    Sávio-Silva C; Soinski-Sousa PE; Balby-Rocha MTA; Lira ÁO; Rangel ÉB
    Rev Assoc Med Bras (1992); 2020 Jan; 66Suppl 1(Suppl 1):s45-s54. PubMed ID: 31939535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mesenchymal Stem Cells: a Promising Therapeutic Tool for Acute Kidney Injury.
    Selim RE; Ahmed HH; Abd-Allah SH; Sabry GM; Hassan RE; Khalil WKB; Abouhashem NS
    Appl Biochem Biotechnol; 2019 Sep; 189(1):284-304. PubMed ID: 30976980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic potential of mesenchymal stem cells in acute kidney injury is affected by administration timing.
    Liu X; Cai J; Jiao X; Yu X; Ding X
    Acta Biochim Biophys Sin (Shanghai); 2017 Apr; 49(4):338-348. PubMed ID: 28338909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypoxic mesenchymal stem cells ameliorate acute kidney ischemia-reperfusion injury via enhancing renal tubular autophagy.
    Tseng WC; Lee PY; Tsai MT; Chang FP; Chen NJ; Chien CT; Hung SC; Tarng DC
    Stem Cell Res Ther; 2021 Jun; 12(1):367. PubMed ID: 34183058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mesenchymal stem cells in acute kidney injury.
    Humphreys BD; Bonventre JV
    Annu Rev Med; 2008; 59():311-25. PubMed ID: 17914926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mesenchymal stem cells alleviate acute kidney injury by down-regulating C5a/C5aR pathway activation.
    Tang M; Zhang K; Li Y; He QH; Li GQ; Zheng QY; Zhang KQ
    Int Urol Nephrol; 2018 Aug; 50(8):1545-1553. PubMed ID: 29594894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-17A improves the efficacy of mesenchymal stem cells in ischemic-reperfusion renal injury by increasing Treg percentages by the COX-2/PGE2 pathway.
    Bai M; Zhang L; Fu B; Bai J; Zhang Y; Cai G; Bai X; Feng Z; Sun S; Chen X
    Kidney Int; 2018 Apr; 93(4):814-825. PubMed ID: 29132705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.